Dermata Stock Future Price Prediction

DRMA -  USA Stock  

USD 1.68  0.17  11.26%

Dermata Therapeutics stock price prediction is an act of determining the future value of Dermata Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Dermata Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Dermata Therapeutics and does not consider all of the tangible or intangible factors available from Dermata Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Dermata Therapeutics, which may create opportunities for some arbitrage if properly timed.
Continue to Dermata Therapeutics Basic Forecasting Models to cross-verify your projections.

Dermata Price Prediction 

 
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Dermata Therapeutics based on different types of headlines from major news networks to social media. The Dermata stock price prediction module provides an analysis of price elasticity to changes in media outlook on Dermata Therapeutics over a specific investment horizon. Using Dermata Therapeutics hype-based prediction, you can estimate the value of Dermata Therapeutics from the perspective of Dermata Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Dermata Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Dermata Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Dermata because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Dermata Therapeutics after-hype prediction price

    
  $ 2.07  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Dermata Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Dermata Therapeutics in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
0.214.1212.92
Details
2 Analysts
Consensus
LowTarget PriceHigh
9.0011.5014.00
Details
Earnings
Estimates (1)
LowProjected EPSHigh
-2.39-2.39-2.39
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Dermata Therapeutics. Your research has to be compared to or analyzed against Dermata Therapeutics' peers to derive any actionable benefits. When done correctly, Dermata Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Dermata Therapeutics.

Dermata Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Dermata Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Dermata Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Dermata Therapeutics, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Dermata Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Dermata Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Dermata Therapeutics' historical news coverage. Dermata Therapeutics' after-hype downside and upside margins for the prediction period are 0.10 and 10.87, respectively. We have considered Dermata Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.68
19th of January 2022
2.07
After-hype Price
10.87
Upside
Dermata Therapeutics is very risky asset. Analysis and calculation of next after-hype price of Dermata Therapeutics is based on 3 months time horizon.

Dermata Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Dermata Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dermata Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Dermata Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 1.16  8.80  0.39   0.01  3 Events / Month0 Events / MonthIn about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.682.0723.21 
2,588  

Dermata Therapeutics Hype Timeline

Dermata Therapeutics is currently traded for 1.68. The entity has historical hype elasticity of 0.39 and average elasticity to hype of competition of -0.01. Dermata is expected to increase in value after the next headline with price projected to jump to 2.07 or above. The average volatility of media hype impact on the company stock price is over 100%. The price jump on the next news is forecasted to be 23.21% whereas the daily expected return is currently at -1.16%. The volatility of related hype on Dermata Therapeutics is about 88000.0% with expected price after next announcement by competition of 1.67. The company has a current ratio of 11.22, suggesting that it is liquid enough and is able to pay its financial obligations when due. Given the investment horizon of 90 days the next expectedpress releasewill be in about 3 days.
Continue to Dermata Therapeutics Basic Forecasting Models to cross-verify your projections.

Dermata Therapeutics Related Hype Analysis

Having access to credible news sources related to Dermata Therapeutics' direct competition is more important than ever and may enhance your ability to predict Dermata Therapeutics' future price movements. Getting to know how Dermata Therapeutics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Dermata Therapeutics may potentially react to the hype associated with one of its peers.

Dermata Therapeutics Additional Predictive Modules

Most predictive techniques to examine Dermata price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Dermata using various technical indicators. When you analyze Dermata charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Dermata Therapeutics Predictive Indicators

The successful prediction of Dermata Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Dermata Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Dermata Therapeutics based on analysis of Dermata Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Dermata Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Dermata Therapeutics's related companies.
 2010 2021 2022 (projected)
Return on Invested Capital11.5210.3710.31
Return on Average Equity1.911.721.71

Story Coverage note for Dermata Therapeutics

The number of cover stories for Dermata Therapeutics depends on current market conditions and Dermata Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Dermata Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Dermata Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Dermata Therapeutics Short Properties

Dermata Therapeutics' future price predictability will typically decrease when Dermata Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Dermata Therapeutics often depends not only on the future outlook of the potential Dermata Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Dermata Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out0.60%
Short Percent Of Float2.83%
Float Shares4.28M
Shares Short Prior Month132.37k
Average Daily Volume Last 10 Day138.27k
Average Daily Volume In Three Month298.01k
Date Short Interest31st of December 2021
Continue to Dermata Therapeutics Basic Forecasting Models to cross-verify your projections. Note that the Dermata Therapeutics information on this page should be used as a complementary analysis to other Dermata Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Dermata Stock analysis

When running Dermata Therapeutics price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Is Dermata Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermata Therapeutics. If investors know Dermata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dermata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Dermata Therapeutics is measured differently than its book value, which is the value of Dermata that is recorded on the company's balance sheet. Investors also form their own opinion of Dermata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dermata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dermata Therapeutics' market value can be influenced by many factors that don't directly affect Dermata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dermata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Dermata Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.